Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma (Q65390192)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma |
clinical trial |
Statements
A Randomised, Double-blind, Placebo Controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients With Locally Advanced and/or Metastatic Renal Cell Carcinoma (English)
0 references
April 2006
0 references
May 2008
0 references
435
0 references
18 year
0 references